cholecystokinin C-terminal flanking peptide

proprotein convertase subtilisin/kexin type 9 ; Homo sapiens







3 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 31653597 From Screening to Targeted Degradation: Strategies for the Discovery and Optimization of Small Molecule Ligands for PCSK9. 2020 Jan 16 2
2 31973581 Preclinical discovery and development of evolocumab for the treatment of hypercholesterolemia. 2020 Apr 2
3 31553664 Ser-Phosphorylation of PCSK9 (Proprotein Convertase Subtilisin-Kexin 9) by Fam20C (Family With Sequence Similarity 20, Member C) Kinase Enhances Its Ability to Degrade the LDLR (Low-Density Lipoprotein Receptor). 2019 Oct 1